GiveBetter x Denver

Savio

In-home youth and family therapy, foster care and parent recovery support

Research time: ~3 min on GPT-6.1 Sol
  • Research — reviewed programs, finances and impact evidence.
  • Modeling — estimated costs, QALYs and uncertainty.
  • Source audit — checked claims, assumptions and calculations.

Updated: 2026-10-06

Donate

Summary

What do they do? Savio provides home-based youth and family therapy with public-service funding and coordination. The matched 2025 reference uses 520 MST clients, not a sum of overlapping statewide programs. It assesses clinical health and signed caregiver resources without assigning children's future wages.

Why we’re interested in this organization:

  • Newest IRS native MST count and full annual expenses are matched to 2025.

  • Home-based family work offers a concrete clinical and access mechanism.

  • Multiple program counts, broad annual reach and public-funded savings are not added as independent benefits.

Our main reservations:

  • Causal completion, utility, alternative-provider additionality and local residence remain hypotheses.

  • Full recipient cost covers foster care, early childhood, trauma and grant administration whose effects are unknown.

  • Near-free family care is not equivalent to cash savings or donor-funded marginal capacity.

What do you get for your dollar? $19.2M per DALY in Denver. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Matched FY2025 full annual recipient cost against partial MST family-treatment benefits; other channels unknown, not whole-portfolio or marginal-gift EV..

Original FY2025 reports 520 MST clients, not completed households; other native program categories are not added.

1. What do they do?

Current home-based services include adolescent family treatment, trauma care, early-childhood caregiver work, foster care and parent substance recovery. Historical residential care closed in 2020 and is not counted as current adolescent capacity. New Bluestem family recovery is a separate current mechanism, not a reason to revive the old adolescent residential program.

2. Monitoring and information sharing

Request deduplicated MST households, completed treatment and fidelity, comparable outcomes against contracted alternatives, caregiver disposable resources, Denver resident share and demonstrable unrestricted-donation capacity. Separate program substitution from treatment received and outcomes gained.

3. Qualitative assessment

FY2025 original reports 520 MST clients plus FFT, sexual-behavior, trauma, family-wellness and foster cohorts; cross-program overlap is unknown, so they are not summed. The annual 1,800 Colorado families reached is not completed unique therapy. Public Medicaid/CYMHTA/county funding and other clinicians form the counterfactual. Broad success narratives do not identify causal QALYs.

4. What do you get for your dollar?

FY2025 full IRS cost $14,274,461 is paired with 520 MST clients. The annual report's $13,906,047 expense differs; no unexplained blending is used. Household conversion .9, completed dose .8, incremental additionality .25, response .4, utility .04 for one year and CBSA share .55 are judgments, not observed causal coefficients. Caregiver $250 net resources are after taxes, benefits withdrawn, childcare and work costs, require completed care and separate .5 resource success, and are not child wages. Positive resource gains receive .5 overlap discount; all exposed families retain $30 time/access cost and .0002 process harm regardless of benefit. Actual otherwise-paid copay and external payer losses are central zero judgments with full-incidence sensitivity. The $7,093,017 adolescent mixed-program cost tests the recognized cost boundary; it is not allocated MST-only or marginal-gift cost. Clinical health and patient process harm use all 520 patients; .9 household conversion applies to caregiver resources only. Original randomized START/START II comparisons against active public services did not establish superior placements or QALYs. The positive access-gap reference is not trial-calibrated: .04 utility is a judged 14.6 healthy-day-equivalent annual improvement among responders, not measured Savio utility. The strong-public-alternative clinical/resource-null scenario is explicit.

Model, assumptions and sensitivity

Full calendar FY2025 IRS functional expense; netted event expenses blank. Only partial MST benefit reference; other channels unknown.

Judged .55 share of MST client households inside ten-county Denver CBSA19740. Statewide programs and Colorado Springs/Western Slope reach prevent assigning all beneficiaries to Denver.

Health = (N patients × b × eligible × completion × response × q × finite discounted duration − full exposed patient harm) × local share. Completed eligible households jointly log net caregiver resources and full home-session costs; all negatives and distinct payer incidence retained. Price = 10 × C / combined health and income equivalents.

C
14274461 USD annual (observed). Observed full FY2025 original functional expenses $14,274,461; netted event direct costs blank. [finance]
N
520 annual observed treatment client envelope (observed). Observed FY2025 MST client envelope 520; household conversion and dose are separate judgments. [annual]
unique
0.9 model parameter (judgment). Judged .9 client-to-household uniqueness; caregiver resources cannot be assigned to overlapping children twice. [services] [cg-cost]
eligible
1 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
completion
0.8 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
b
0.25 model parameter (judgment). Judged .25 incremental care against public contracts and alternate providers; not treatment-model efficacy. [services] [cg-cost]
response
0.4 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
q
0.04 model parameter (judgment). Judged .04 annual utility (14.6 healthy-day-equivalents) among clinical responders in an incremental access-gap regime, not trial-calibrated. Active-care START II QALYs showed no significant superiority; null regime retained. [services] [cg-cost]
T
1 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
g
0.55 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
delay
0.1 model parameter (judgment). Judged .1-year engagement start for care and access costs/resources together. [services] [cg-cost]
r
0.03 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
harm
0.0002 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
success
0.5 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
workGain
250 model parameter (judgment). Judged $250 net caregiver household gain after taxes, benefits, childcare and work costs; no child gross or lifetime wages. [services] [cg-cost]
medicalGain
0 model parameter (judgment). Judged zero actual otherwise-paid copay avoidance, not retail service value. [services] [cg-cost]
overlap
0.5 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
cost
30 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
baseline
20000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerLoss
0 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
externalCost
0 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerPeople
10000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerBaseline
50000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]

central: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

active public alternative clinical and resource null: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

clinical patient unit no household reduction: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.06. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

clinical null: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

financial only: Cost: $14.3M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

zero benefit full burdens: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no exposure: Cost: $14.3M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no gift no exposure: Cost: $0; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

adverse: Cost: $14.3M; Denver health QALYs: -1.88; all-population health QALYs: -3.42. Income-equivalent healthy years: -0.52. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

unknown: Cost: unknown; Denver health QALYs: unknown; all-population health QALYs: unknown. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no recipient resources: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

clinical response null: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

short health: Cost: $14.3M; Denver health QALYs: 0.17; all-population health QALYs: 0.31. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

one year health: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

low additionality: Cost: $14.3M; Denver health QALYs: 0.31; all-population health QALYs: 0.56. Income-equivalent healthy years: -0.16. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

all additionality: Cost: $14.3M; Denver health QALYs: 3.59; all-population health QALYs: 6.53. Income-equivalent healthy years: 0.13. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

half geography: Cost: $14.3M; Denver health QALYs: 0.39; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.05. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no local share: Cost: $14.3M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no positive overlap: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

full positive overlap: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.03. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

negative overlap zero: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.28. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

negative overlap one: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.28. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

mixed resources: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.25. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no access cost: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: 0.08. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

high access cost: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.24. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

higher payer incidence: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.14. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

higher volunteer opportunity: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.32. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

double cost: Cost: $28.5M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

recognized mixed community program cost: Cost: $7.1M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

half connections: Cost: $14.3M; Denver health QALYs: 0.43; all-population health QALYs: 0.78. Income-equivalent healthy years: -0.06. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

higher connections: Cost: $14.3M; Denver health QALYs: 1.28; all-population health QALYs: 2.33. Income-equivalent healthy years: -0.17. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

household deduplication: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.09. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no net work gain: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

higher after cost work: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.03. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no eligible subgroup: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no completed dose: Cost: $14.3M; Denver health QALYs: -0.06; all-population health QALYs: -0.10. Income-equivalent healthy years: -0.19. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

low clinical response: Cost: $14.3M; Denver health QALYs: 0.06; all-population health QALYs: 0.10. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no copay otherwise paid: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

three full year mean cost: Cost: $13.7M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

low completed dose: Cost: $14.3M; Denver health QALYs: 0.06; all-population health QALYs: 0.10. Income-equivalent healthy years: -0.18. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

no volunteer opportunity: Cost: $14.3M; Denver health QALYs: 0.86; all-population health QALYs: 1.56. Income-equivalent healthy years: -0.11. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

full completed dose: Cost: $14.3M; Denver health QALYs: 1.08; all-population health QALYs: 1.97. Income-equivalent healthy years: -0.09. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

Counterfactual: County/Medicaid contracted care, other family treatment and justice services without Savio; home access and fidelity may differ.

Attribution: Judged .25 incremental additionality against publicly funded substitute providers, completion .8 and response .4. Native enrollment is not causal outcome.

Clinical utility, duration, completion, family overlap, actual substitute provision, caregiver gain, local share and next-gift capacity unmeasured. Other programs unknown, not zero.

Sensitivity

  • active public alternative clinical and resource null: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • clinical patient unit no household reduction: $18.0M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • clinical null: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • financial only: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • zero benefit full burdens: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no exposure: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no gift no exposure: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • adverse: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • unknown: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no recipient resources: $21.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • clinical response null: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • short health: $243.8M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • one year health: $19.2M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • low additionality: $96.9M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • all additionality: $3.8M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • half geography: $42.3M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no local share: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no positive overlap: $21.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • full positive overlap: $17.4M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • negative overlap zero: $24.7M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • negative overlap one: $24.7M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • mixed resources: $23.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no access cost: $15.3M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • high access cost: $23.2M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • higher payer incidence: $19.9M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • higher volunteer opportunity: $26.6M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • double cost: $38.4M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • recognized mixed community program cost: $9.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • half connections: $38.4M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • higher connections: $12.8M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • household deduplication: $18.6M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no net work gain: $21.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • higher after cost work: $17.4M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no eligible subgroup: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no completed dose: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • low clinical response: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no copay otherwise paid: $19.2M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • three full year mean cost: $18.5M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • low completed dose: no finite positive estimate. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • no volunteer opportunity: $19.2M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.
  • full completed dose: $14.4M per DALY. Conditional FY2025 MST client envelope, not summed statewide families or completed successes. Clinical utility, household deduplication, completion, public-provider additionality and caregiver resources are hypotheses. Full annual costs include unknown other channels.

Unresolved inputs

  • Completed unique MST households and fidelity
  • Controlled recipient effects and utility
  • Net caregiver resources and payer incidence
  • Measured Denver resident share
  • Allocated MST cost and current unrestricted gift capacity

Health and income breakdown

For the modeled $14.3M: 0.86 health QALYs + -0.11 income-equivalent healthy years in Denver: $19.2M per DALY. Income equivalents are welfare comparisons, not observed QALYs or DALYs.

Method and caveats.

5. Funding and previous grants

Current giving page identifies Savio House Inc. DBA Savio, EIN 84-0570279, Stripe processing and greatest-need giving unless restricted. No transaction was made. Statewide contracts and Medicaid support can substitute for donated funding; government expenditure or retail free therapy value is not automatically net family consumption. New program needs indicate possible uses, not measured next-dollar impact.

Annual expenses

Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.

  • FY 2025: $14.3M; ein:84-0570279, 12-month period, IRS full functional expenses plus netted direct event expenses. Source
  • FY 2024: $14.2M; ein:84-0570279, 12-month period, IRS full functional expenses plus netted direct event expenses. Source
  • FY 2023: $12.7M; ein:84-0570279, 12-month period, IRS full functional expenses plus netted direct event expenses. Source

6. Sources

  1. Current home-based adolescent care and public billing. Savio. Published: not stated; retrieved: 2026-10-06.
  2. FY2025 original MST client and other program envelope. Savio. Published: not stated; retrieved: 2026-10-06.
  3. FY2025 original annual full expenses. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  4. FY2024 original annual expenses. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  5. FY2023 original annual expenses. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  6. 2025 annual broad statewide reach and separate financial total. Savio. Published: not stated; retrieved: 2026-10-06.
  7. Current legal recipient and greatest-need donation route. Savio. Published: not stated; retrieved: 2026-10-06.
  8. Health and signed net income comparison framework. Coefficient Giving. Published: not stated; retrieved: 2026-10-06.
  9. Original randomized MST versus active usual-care trial. Savio. Published: not stated; retrieved: 2026-10-06.
  10. Original START II EQ-5D clinical/economic summary. Savio. Published: not stated; retrieved: 2026-10-06.